Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | 139,00 € | 236,30 € | 70,00 % |
| Neurocrine Bioscience | 28 | 0 | 7 | 0 | 126,15 € | 140,34 € | 11,25 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,72 € | 26,01 € | 31,88 % |
| United Therapeutics | 18 | 0 | 3 | 0 | 245,40 € | 288,66 € | 17,63 % |
| Merit Medical Systems | 17 | 0 | 5 | 0 | 74,00 € | 86,90 € | 17,43 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | 38,00 € | 84,74 € | 123,01 % |
| Insulet Corp. | 16 | 0 | 2 | 0 | 149,20 € | 215,54 € | 44,46 % |
| Amedisys Inc. | 14 | 0 | 1 | 0 | 87,00 € | 92,26 € | 6,05 % |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | 40,44 € | 50,33 € | 24,46 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 151,35 € | 184,76 € | 22,07 % |
| CONMED Corp. | 12 | 1 | 4 | 0 | 66,00 € | 106,18 € | 60,88 % |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | 76,00 € | 75,94 € | -0,08 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 361,00 € | 421,61 € | 16,79 % |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | 110,00 € | 116,99 € | 6,36 % |
| Xencor Inc. | 10 | 1 | 2 | 0 | 22,60 € | 32,58 € | 44,15 % |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | 29,20 € | 41,81 € | 43,20 % |
| Masimo Corp. | 7 | 1 | 2 | 0 | 113,00 € | 147,62 € | 30,63 % |
| Bruker Corp. | 7 | 1 | 0 | 0 | 68,78 € | 85,68 € | 24,58 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | 31,00 € | 38,99 € | 25,77 % |
| Myriad Genetics | 6 | 2 | 1 | 0 | 23,00 € | 25,14 € | 9,32 % |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | 99,50 € | 124,85 € | 25,48 % |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | 1,63 € | 3,70 € | 127,41 % |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | 100,15 € | - | - |
| Davita Inc. | 2 | 0 | 0 | 0 | 126,60 € | 124,89 € | -1,35 % |
| Healthequity Inc. | 1 | 0 | 0 | 0 | 71,50 € | 79,00 € | 10,49 % |